B. Patel

发表

Myeloid dendritic cells are major producers of interferon-β in dermatomyositis and may contribute to hydroxychloroquine refractoriness.

V. Werth, B. White, M. Wysocka, 2021, The Journal of investigative dermatology.

Increased MxA protein expression and dendritic cells in spongiotic dermatitis differentiates dermatomyositis from eczema in a single‐center case‐control study

V. Werth, M. Zeidi, Kristen L. Chen, 2020, Journal of cutaneous pathology.

Applicability of EULAR/ACR classification criteria for dermatomyositis to amyopathic disease

V. Werth, B. Patel, N. Khan, 2017, Journal of the American Academy of Dermatology.

Developing classification criteria for skin‐predominant dermatomyositis: the Delphi process

Y. Yamaguchi, J. Callen, M. Fujimoto, 2019, The British journal of dermatology.

Topical corticosteroid compounding: effects on physicochemical stability and skin penetration rate.

B. Patel, J. Rodgers, L. Krochmal, 1989, Journal of the American Academy of Dermatology.

Evaluation of the reliability and validity of the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) in paediatric cutaneous lupus among paediatric dermatologists and rheumatologists

J. Treat, V. Werth, L. Castelo-Soccio, 2018, The British journal of dermatology.

Topical product design and extemporaneous compounding in dermatology.

B. Patel, L. Krochmal, 1992, Advances in dermatology.

Dermatomyositis: A diagnostic dilemma

V. Werth, B. Patel, D. M. Da Silva, 2018, Journal of the American Academy of Dermatology.

Comment on “Dermatology residents and the care of COVID-19 patients”

B. Patel, 2020, Journal of the American Academy of Dermatology.

AB002. Evaluation of the reliability and validity of the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) in pediatric cutaneous lupus among pediatric dermatologists and rheumatologists

J. Treat, V. Werth, L. Castelo-Soccio, 2019, Annals of Translational Medicine.